Literature DB >> 23111168

What you always needed to know about electroporation based DNA vaccines.

Anita Gothelf1, Julie Gehl.   

Abstract

Vaccinations are increasingly used to fight infectious disease, and DNA vaccines offer considerable advantages, including broader possibilities for vaccination and lack of need for cold storage. It has been amply demonstrated, that electroporation augments uptake of DNA in both skin and muscle, and it is foreseen that future DNA vaccination may to a large extent be coupled with and dependent upon electroporation based delivery. Understanding the basic science of electroporation and exploiting knowledge obtained on optimization of DNA electrotransfer to muscle and skin, may greatly augment efforts on vaccine development. The purpose of this review is to give a succinct but comprehensive overview of electroporation as a delivery modality including electrotransfer to skin and muscle. As well, this review will speculate and discuss future uses for this powerful electrotransfer technology.

Entities:  

Keywords:  DNA vaccine; electroporation; gene electrotransfer; gene therapy; gene transfection; muscle; skin

Mesh:

Substances:

Year:  2012        PMID: 23111168      PMCID: PMC3601144          DOI: 10.4161/hv.22062

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  45 in total

Review 1.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

2.  Pore disappearance in a cell after electroporation: theoretical simulation and comparison with experiments.

Authors:  G Saulis
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

3.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses.

Authors:  L M Mir; M F Bureau; J Gehl; R Rangara; D Rouy; J M Caillaud; P Delaere; D Branellec; B Schwartz; D Scherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Voltage-induced pore formation and hemolysis of human erythrocytes.

Authors:  K Kinosita; T Y Tsong
Journal:  Biochim Biophys Acta       Date:  1977-12-01

5.  Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs.

Authors:  Amir S Khan; Louis C Smith; Ronald V Abruzzese; Kathleen K Cummings; Melissa A Pope; Patricia A Brown; Ruxandra Draghia-Akli
Journal:  DNA Cell Biol       Date:  2003-12       Impact factor: 3.311

6.  Skin-specific promoters for genetic immunisation by DNA electroporation.

Authors:  Gaëlle Vandermeulen; Hervé Richiardi; Virginie Escriou; Jing Ni; Philippe Fournier; Volker Schirrmacher; Daniel Scherman; Véronique Préat
Journal:  Vaccine       Date:  2009-05-29       Impact factor: 3.641

7.  Sensitive and precise regulation of haemoglobin after gene transfer of erythropoietin to muscle tissue using electroporation.

Authors:  P Hojman; H Gissel; J Gehl
Journal:  Gene Ther       Date:  2007-04-05       Impact factor: 5.250

8.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

Review 9.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

10.  Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin.

Authors:  F M André; J Gehl; G Sersa; V Préat; P Hojman; J Eriksen; M Golzio; M Cemazar; N Pavselj; M-P Rols; D Miklavcic; E Neumann; J Teissié; L M Mir
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 4.793

View more
  25 in total

1.  Measuring the potential energy barrier to lipid bilayer electroporation.

Authors:  Jason T Sengel; Mark I Wallace
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

2.  Current Progress in Electrotransfection as a Nonviral Method for Gene Delivery.

Authors:  Lisa D Cervia; Fan Yuan
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

3.  A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.

Authors:  Jay R McCoy; Janess M Mendoza; Kristin W Spik; Catherine Badger; Alan F Gomez; Connie S Schmaljohn; Niranjan Y Sardesai; Kate E Broderick
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Imaging the dynamics of individual electropores.

Authors:  Jason T Sengel; Mark I Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

5.  Electroporation-mediated gene delivery.

Authors:  Jennifer L Young; David A Dean
Journal:  Adv Genet       Date:  2014-12-11       Impact factor: 1.944

6.  Electrotransfection and lipofection show comparable efficiency for in vitro gene delivery of primary human myoblasts.

Authors:  Tomaz Mars; Marusa Strazisar; Katarina Mis; Nejc Kotnik; Katarina Pegan; Jasna Lojk; Zoran Grubic; Mojca Pavlin
Journal:  J Membr Biol       Date:  2014-12-23       Impact factor: 1.843

7.  Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.

Authors:  Jessie Thalmensi; Elodie Pliquet; Christelle Liard; Marie Escande; Thomas Bestetti; Marion Julithe; Anna Kostrzak; Anne-Sophie Pailhes-Jimenez; Emanuèle Bourges; Maria Loustau; Julien Caumartin; Abderrahim Lachgar; Thierry Huet; Simon Wain-Hobson; Pierre Langlade-Demoyen
Journal:  Oncoimmunology       Date:  2015-11-05       Impact factor: 8.110

8.  A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.

Authors:  Juliet Mpendo; Gaudensia Mutua; Julien Nyombayire; Rosine Ingabire; Annet Nanvubya; Omu Anzala; Etienne Karita; Peter Hayes; Jakub Kopycinski; Len Dally; Drew Hannaman; Michael A Egan; John H Eldridge; Kristen Syvertsen; Jennifer Lehrman; Beth Rasmussen; Jill Gilmour; Josephine H Cox; Patricia E Fast; Claudia Schmidt
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 9.  DNA vaccines: a simple DNA sensing matter?

Authors:  Cevayir Coban; Kouji Kobiyama; Nao Jounai; Miyuki Tozuka; Ken J Ishii
Journal:  Hum Vaccin Immunother       Date:  2013-08-02       Impact factor: 3.452

10.  Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo: Enhanced gene transfer and adjuvant activity.

Authors:  Christophe Y Calvet; Franck M André; Lluis M Mir
Journal:  Oncoimmunology       Date:  2014-04-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.